An emerging role for microRNAs in NF1 tumorigenesis

Human Genomics

Volumn 6, Issue 1, 2012, Pages

  Sedani, Ashni ^a   Cooper, David N ^a   Upadhyaya, Meena ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Malignant peripheral nerve sheath tumours; MicroRNAs; Neurofibromatosis type 1; Tumorigenesis

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 204; MICRORNA 21; MICRORNA 214; MICRORNA 29C; MICRORNA 34A; TUMOR MARKER; UNCLASSIFIED DRUG;

CARCINOGENESIS; EPIGENETICS; HUMAN; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; REVIEW; BIOGENESIS; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; NEURILEMOMA; NEUROFIBROMA;

BIOGENESIS; CELL TRANSFORMATION, NEOPLASTIC; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEURILEMMOMA; NEUROFIBROMA; NEUROFIBROMATOSIS 1;

MLCS; MLOWN;

EID: 84876577533     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-6-23     Document Type: Review

References (82)

1. Ambros V: The functions of animal microRNAs. Nature 2001, 431:350-355.
2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004, 116:281-297.
3. Lai EC: MicroRNAs are complementary to 30UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002, 30:363-364.
4. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
5. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabtidis elegans. Nature 2000, 403:901-906.
6. Pasquinelli AE, Reinhart BJ, Slack FJ, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Muller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G: Conservation of the sequence and temporal expression of Let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
7. Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du ZW, Zhang JW: Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun 2006, 13:59-68.
8. Sayed D, Abdellatif M: MicroRNAs in development and disease. Physiol Rev 2011, 91:827-887.
9. Ladomery MR, Maddocks DG, Wilson ID: MicroRNAs: their discovery, biogenesis, function and potential use as biomarkers in non-invasive prenatal diagnostics. Int J Mol Epidemiol Genet 2011, 2:253-260.
10. Lee Y, Jeon K, Lee JT, Kim S, Kim VN: MicroRNA maturation: stepwise processing and subcellular localisation. EMBO J 2002, 23:4051-4060.
11. Zeng Y, Yi R, Cullen BR: Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J 2005, 24:138-148.
12. Denli AM, Tops BBJ, Plasterk RHA, Ketting RF, Hannon GJ: Processing of primary microRNAs by the microprocessor complex. Nature 2004, 432:231-235.
13. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhatter R: The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
14. Landthaler M, Yalcin A, Tuschl T: The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 2004, 14:2162-2167.
15. Yi R, Qin Y, Macara IG, Cullen BR: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016.
16. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U: Nuclear export of microRNA precursors. Science 2004, 303:95-98.
17. Hwang HW, Mendell JT: MicroRNAs in cell proliferation, cell death and tumourigenesis. Br J Cancer 2006, 94:776-780.
18. Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD: Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 2005, 123:607-620.
19. Winter J, Jung S, Keller S, Gregory RI, Diederichs S: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009, 11:228-234.
20. Tan G, Shi Y, Wu ZH: MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN. Biochem Biophys Res Commun 2012, 2012 (417):546-551.
21. Hawkins PG, Morris KV: RNA and transcriptional modification of gene expression. Cell Cycle 2008, 7:602-607.
22. Esquela-Kerscher A, Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
23. Hammond SM: MicroRNA detection comes of age. Nat Methods 2006, 3:12-13.
24. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33:e179.
25. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM: An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Nat Acad Sci USA 2004, 101:9740-9744.
26. Neely LA, Patel S, Garver J, Gallo M, Hackett M, McLaughlin S, Nadel M, Harris J, Gullans S, Rooke J: A single-molecule method for the quantitation of microRNA gene expression. Nat Methods 2006, 3:41-46.
27. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
28. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, et al: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008, 26:462-469.
29. Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R: Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 2012, 16:8-21.
30. Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, Sun J, Guo AY: Genomewide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 2012, 33:254-263.
31. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G: microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006, 103:9136-9141.
32. Marcinkowska M, Szymanski M, Krzyzosiak WJ, Kozlowski P: Copy number variation of microRNA genes in the human genome. BMC Genomics 2011, 12:183.
33. Upadhyaya M: Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors. Front Biosci 2011, 16:937-951.
34. Cheng AM, Byrom MW, Shelton J, Ford LP: Antisense inhibition of human miRNAs and indications for involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33:1290-1297.
35. Cimmino A, Calin GA, Fabri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqelin RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005, 102:13944-13949.
36. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004, 101:2999-3004.
37. Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M: Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol 2010, 220:58-70.
38. Chai G, Liu N, Ma J, Li H, Oblinger JL, Prahalad AK, Gong M, Chang LS, Wallace M, Muir D, Guha A, Phipps RJ, Hock JM, Yu X: MicroRNA-10b regulates tumourigenesis in neurofibromatosis type 1. Cancer Sci 2010, 101:1997-2004.
39. Presneau N, Eskandarpour MS, Henderson S, Halai D, Tirabosco R, Flanagan AM: Micro-RNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. Br J Cancer 2012, doi:10.1038/bjc.2012.518.
40. Gong M, Ma J, Li M, Zhou M, Hock JM, Yu X: MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neuro Oncol 2012, 14:1007-1017.
41. Itani S, Kunisada T, Morimoto Y, Yoshida A, Sasaki T, Ito S, Ouchida M, Sugihara S, Shimizu K, Ozaki T: MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). J Cancer Res Clin Oncol 2012, 138:1501-1509.
42. Lee Ming J, Choji H, Galas DJ, Wang K: The systems biology of neurofibromatosis type 1 - critical roles for microRNA. Exp Neurol 2012, 235:464-464.
43. Lammens T, Li J, Leone G, De Veylder L: Atypical E2Fs: new players in the E2F transcription factor family. Trends Cell Biol 2009, 19:111-118.
44. Reimer D, Sadr S, Wiedemair A, Stadlmann S, Concin N, Hofstetter G, Müller-Holzner E, Marth C, Zeimet AG: Clinical relevance of E2F family members in ovarian cancer - an evaluation in a training set of 77 patients. Clin Cancer Res 2007, 13:144-151.
45. Yin D, Ogawa S, Kawamata N, Leiter A, Ham M, Li D, Doan NB, Said JW, Black KL, Koeffler PH: miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene 2012, 10:1038.
46. Li L, Yuan L, Luo J, Gao J, Guo J, Xie X: MiR-34a inhibits proliferation and migration of breast cancer hrough down-regulation of Bcl-2 and SIRT1. Clin Exp Med 2012, doi:10.1007/s10238-012-0186-5.
47. Kumar B, Yadav A, Lang J, Teknos TN, Kumar P: Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS One 2012, 7:e37601.
48. Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q, Ma B: MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One 2012, 7:e33778.
49. Schwarzenbach H, Milde-Langosch K, Steinbach B, Müller V, Pantel K: Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. Breast Cancer Res Treat 2012, 134:933-941.
50. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008, 68:425-433.
51. Peng RQ, Wan HY, Li HF, Liu M, Li X, Tang H: MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-Nacetyl-α-D-galactosamine:polypeptide N- acetylgalactosaminyltransferase 7. J Biol Chem 2012, 287:14301-14309.
52. Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, Lee YS, Yen TC, Hsieh SY: MicroRNA-214 downregulation contributes to tumor angiogenesis via inducing secretion of hepatoma-derived growth factor in human hepatoma. J Hepatol 2012, 57:584-591.
53. Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB: Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 2009, 1:123-128.
54. Tanzer A, Amemiya CT, Kim CB, Stadler PF: Evolution of microRNAs located within Hox gene clusters. J Exp Zool B Mol Dev Evol 2005, 304:75-85.
55. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B: Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008, 105:3945-3950.
56. Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
57. Kwiecinski M, Noetel A, Elfimova N, Trebicka J, Schievenbusch S, Strack I, Molnar L, von Brandenstein M, Töx U, Nischt R, Coutelle O, Dienes HP, Odenthal M: Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS One 2011, 6:e24568.
58. Kuo TY, Hsi E, Yang IP, Tsai PC, Wang JY, Juo SH: Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS One 2012, 7:e31587.
59. Wang CM, Wang Y, Fan CG, Xu FF, Sun WS, Liu YG, Jia JH: miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem Biophys Res Commun 2011, 411:586-592.
60. Bauer VL, Braselmann H, Henke M, Mattern D, Walch A, Unger K, Baudis M, Lassmann S, Huber R, Wienberg J, Werner M, Zitzelsberger HF: Chromosomal changes characterize head and neck cancer with poor prognosis. J Mol Med 2008, 86:1353-1365.
61. Wang FE, Zhang C, Maminishkis A, Dong L, Zhi C, Li R, Zhao J, Majerciak V, Gaur AB, Chen S, Miller SS: MicroRNA-204/211 alters epithelial physiology. FASEB J 2010, 24:1552-1571.
62. Kluwe L, Siebert R, Gesk S, Friedrich RE, Tinschert S, Kehrer-Sawatzki H, Mautner VF: Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat 2004, 23:111-116.
63. Dorschner MO, Sybert VP, Weaver M, Pletcher BA, Stephens K: NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 2000, 9:35-46.
64. De Raedt T, Brems H, Lopez-Correa C, Vermeesch JR, Marynen P, Legius E: Genomic organization and evolution of the NF1 microdeletion region. Genomics 2004, 84:346-360.
65. Upadhyaya M, Ruggieri M, Maynard J, Osborn M, Hartog C, Mudd S, Penttinen M, Cordeiro I, Ponder M, Ponder BAJ, Krawczak M, Cooper DN: Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 1998, 102:591-597.
66. Jenne DE, Tinschert S, Dorschner MO, Hameister H, Stephens K, Kehrer-Sawatzki H: Complete physical map and gene content of the human NF1 tumour suppressor region in human and mouse. Genes Chrom Cancer 2003, 37:111-120.
67. Pasmant E, Masliah-Planchon J, Lévy P, Laurendeau I, Ortonne N, Parfait B, Valeyrie-Allanore L, Leroy K, Wolkenstein P, Vidaud M, Vidaud D, Bièche I: Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients. Mol Med 2011, 17:79-87.
68. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J: Exploration of tumoursuppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008, 68:2094-2105.
69. Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y, Du X, Han W: microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting cyclin D1 and Bcl-2. Carcinogenesis 2012, 33:220-225.
70. Tömböl Z, Eder K, Kovács A, Szabó PM, Kulka J, Likó I, Zalatnai A, Rácz G, Tóth M, Patócs A, Falus A, Rácz K, Igaz P: MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. Mod Pathol 2010, 23:1583-1595.
71. Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA: Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res 2011, 717:77-84.
72. Su Z, Xia J, Zhao Z: Functional complementation between transcriptional methylation regulation and post-transcriptional microRNA regulation in the human genome. BMC Genomics 2011, 5:S15.
73. Nana-Sinkam SP, Croce CM: MicroRNAs as therapeutic targets in cancer. Transl Res 2011, 157:216-225.
74. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M: Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
75. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW: MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009, 361:1437-1447.
76. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006, 2006(130):2113-2129.
77. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S, Majumder S: MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 2008, 283:29897-29903.
78. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ: MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem2008, 283:31079-31086.
79. Izzotti A: Molecular medicine and the development of cancer chemopreventive agents. Ann N Y Acad Sci 2012, 1259:26-32.
80. Han Y, Liu Y, Gui Y, Cai Z: Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder. J Surg Oncol 2012, doi:10.1002/jso.23214. Epub ahead of print.
81. Steer CJ, Subramanian S: Circulating microRNAs as biomarkers: a new frontier in diagnostics. Liver Transpl 2012, 18:265-269.
82. Ajit SK: Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors (Basel) 2012, 12:3359-3369.